Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000317

Director acquired 18,208 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
THOMPSON VIRGIL Director 2022-12-31 Option exercise +18,208 100,213 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
THOMPSON VIRGIL Director 2023-01-01 Grant or award · Restricted Stock +30,000 30,000 D: show line 2 in the form
Loading xslF345X03/doc1.xml…